{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:10:31Z","timestamp":1790143831654,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bbrc.2020.01.054","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:40:56Z","timestamp":1579653656000},"page":"51-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins"],"prefix":"10.1016","volume":"531","author":[{"given":"Sefan","family":"Asamitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ikenoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9540-1354","authenticated-orcid":false,"given":"Takahito","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-8328","authenticated-orcid":false,"given":"Norifumi","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.01.054_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/334364a0","article-title":"Formation of parallel 4-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis","volume":"334","author":"Sen","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.054_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/351331a0","article-title":"Tetramerization of an RNA oligonucleotide containing a GGGG sequence","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.054_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/342825a0","article-title":"Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops","volume":"342","author":"Sundquist","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.054_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0092-8674(89)90610-7","article-title":"Monovalent cation-induced structure of telomeric DNA: the G-Quartet model","volume":"59","author":"Williamson","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.054_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0282(2000\/2001)56:3<123::AID-BIP10010>3.0.CO;2-3","article-title":"Quadruplex structures in nucleic acids","volume":"56","author":"Keniry","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbrc.2020.01.054_bib6","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1016\/j.bmc.2009.08.043","article-title":"A\u00a0comparison of DNA and RNA quadruplex structures and stabilities","volume":"17","author":"Joachimi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2020.01.054_bib7","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1021\/bi200805j","article-title":"Sequence-independent analysis of the loop length dependence of intramolecular RNA G-quadruplex stability and topology","volume":"50","author":"Zhang","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2020.01.054_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3662","article-title":"G-quadruplex structures mark human regulatory chromatin","volume":"10","author":"H\u00e4nsel-Hertsch","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nmeth.3965","article-title":"rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome","volume":"10","author":"Kwok","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2020.01.054_bib10","doi-asserted-by":"crossref","first-page":"aaf5371","DOI":"10.1126\/science.aaf5371","article-title":"RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria","volume":"353","author":"Guo","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.01.054_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrm.2017.3","article-title":"DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential","volume":"18","author":"H\u00e4nsel-Hertsch","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.tibtech.2017.06.012","article-title":"G-Quadruplexes: prediction, characterization, and biological application","volume":"35","author":"Kwok","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib13","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jmb.2017.05.017","article-title":"RNA G-quadruplexes in biology: principles and molecular mechanisms","volume":"429","author":"M Fay","year":"2017","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tig.2018.11.001","article-title":"Non-duplex G-quadruplex structures emerge as mediators of epigenetic modifications","volume":"35","author":"Mukherjee","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib15","doi-asserted-by":"crossref","first-page":"E2884","DOI":"10.3390\/ijms20122884","article-title":"Perspectives for applying G-Quadruplex structures in neurobiology and neuropharmacology","volume":"20","author":"Asamitsu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.01.054_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"Balasubramanian","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2020.01.054_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/molecules24030429","article-title":"Recent progress of targeted G-quadruplex-preferred ligands toward cancer therapy","volume":"24","author":"Asamitsu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2020.01.054_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/chem.201802691","article-title":"Ligand design to acquire specificity to intended G-quadruplex structures","volume":"25","author":"Asamitsu","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.bbrc.2020.01.054_bib19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41591-018-0018-6","article-title":"Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome","volume":"24","author":"Shioda","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.01.054_bib20","article-title":"5-Aminolevulinic acid can ameliorate language dysfunction of patients with ATR-X syndrome","author":"Wada","year":"2019","journal-title":"Congenital. Anom."},{"key":"10.1016\/j.bbrc.2020.01.054_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A\u00a0hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/srep01016","article-title":"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G- quadruplexes","volume":"2","author":"Fratta","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.01.054_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-013-1200-z","article-title":"C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci","volume":"126","author":"Mizielinska","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS 77","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib28","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.01.054_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.01.054_bib30","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nn.4604","article-title":"C9orf72 expansion disrupts ATM- mediated chromosomal break repair","volume":"20","author":"Walker","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2020.01.054_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/nyas.12693","article-title":"Fragile X-associated tremor\/ataxia syndrome","volume":"1338","author":"Hagerman","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2020.01.054_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/brain\/awh650","article-title":"Protein composition of the intranuclear inclusions of FXTAS","volume":"129","author":"Iwahashi","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2020.01.054_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib34","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41588-019-0459-y","article-title":"Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease","volume":"51","author":"Sone","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib35","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/s41588-019-0458-z","article-title":"Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease","volume":"51","author":"Ishiura","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2009.02.011","article-title":"RNA and disease","volume":"136","author":"Cooper","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.054_bib37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1042\/BCJ20160499","article-title":"RNA-binding proteins with prion-like domains in health and disease","volume":"474","author":"Harrison","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2020.01.054_bib38","doi-asserted-by":"crossref","first-page":"E2341","DOI":"10.3390\/molecules23092341","article-title":"The amino acid composition of quadruplex binding proteins reveals a shared motif and predicts new potential quadruplex interactors","volume":"23","author":"Br\u00e1zda","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2020.01.054_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg3813","article-title":"A\u00a0census of human RNA-binding proteins","volume":"15","author":"Gerstberger","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib40","first-page":"1","article-title":"Stress granules and neurodegeneration","author":"Wolozin","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2020.01.054_bib41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.15252\/embr.201540607","article-title":"G4-associated human diseases","volume":"16","author":"Maizels","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2020.01.054_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.054_bib43","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1073\/pnas.0704057104","article-title":"Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX","volume":"104","author":"Argentaro","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.01.054_bib44","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/hmg\/ddr107","article-title":"The ATRX\u2013ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9","volume":"20","author":"Dhayalan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nsmb.2062","article-title":"ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome","volume":"18","author":"Iwase","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib46","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/hmg\/5.12.1899","article-title":"ATRX encodes a novel member of the SNF2 family of proteins: mutations point a common mechanism underlying the ATR-X syndrome","volume":"5","author":"Picketts","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib47","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/hmg\/ddr163","article-title":"Functional significance of mutations in the Snf2 domain of ATRX","volume":"20","author":"Mitson","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.01.054_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2010.09.023","article-title":"ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner","volume":"143","author":"Law","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.01.054_bib49","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cbic.201500655","article-title":"Effect of ATRX and G-quadruplex formation by the VNTR sequence on \u03b1-Globin gene expression","volume":"17","author":"Li","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbrc.2020.01.054_bib50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/humu.20734","article-title":"Mutations in the chromatin-associated protein ATRX","volume":"29","author":"Gibbons","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbrc.2020.01.054_bib51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1523\/JNEUROSCI.4816-10.2011","article-title":"Aberrant calcium\/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain","volume":"31","author":"Shioda","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2020.01.054_bib52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hipo.20782","article-title":"Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice","volume":"21","author":"Nogami","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbrc.2020.01.054_bib53","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI65634","article-title":"Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span","volume":"123","author":"Watson","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2020.01.054_bib54","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.01.054_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9orf72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2020.01.054_bib56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA toxicity from the ALS\/FTD C9orf72 expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.01.054_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly (GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2020.01.054_bib59","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/ja981554t","article-title":"Intercalative G-tetraplex stabilization of telomeric DNA by a cationic Porphyrin","volume":"121","author":"Haq","year":"1999","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2020.01.054_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.01.054_bib61","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1093\/nar\/gkg453","article-title":"The cationic porphyrin TMPyP4 destabilizes the tetraplex form of the fragile X syndrome expanded sequence d(CGG)n","volume":"31","author":"Weisman-Shomer","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2020.01.054_bib62","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/nar\/gkp130","article-title":"The quadruplex r(CGG)n destabilizing cationic porphyrin TMPyP4 cooperates with hnRNPs to increase the translation efficiency of fragile X premutation mRNA","volume":"37","author":"Ofer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2020.01.054_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nec.2012.04.001","article-title":"Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid)","volume":"23","author":"Roberts","year":"2012","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2020.01.054_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-019-03098-y","article-title":"5-ALA and FDA approval for glioma surgery","volume":"141","author":"Hadjipanayis","year":"2019","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.bbrc.2020.01.054_bib65","article-title":"The safety and tolerability of 5-aminolevulinic acid phosphate with sodium ferrous citrate in patients with type 2 diabetes mellitus in Bahrain","volume":"2016","author":"Al-Saber","year":"2016","journal-title":"J.\u00a0Diabetes. Res."},{"key":"10.1016\/j.bbrc.2020.01.054_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.301.2.507","article-title":"Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer","volume":"301","author":"Dalton","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2020.01.054_bib67","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjc.6600559","article-title":"ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice","volume":"87","author":"Perotti","year":"2002","journal-title":"Br. J. Canc."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20301236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20301236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:56:08Z","timestamp":1757764568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20301236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0006291X20301236"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.054","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}